Consider diabetic hypoglycaemia in a patient with diabetes who has any symptoms or signs of hypoglycaemia, which includes neuroglycopenic and sympathoadrenal signs and symptoms, or if they present following a fall or motor vehicle accident.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
Diabetic hypoglycaemia is confirmed if finger stick measurement of blood glucose is <3.9 mmol/L (<70 mg/dL).[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
Severity of diabetic hypoglycaemia is classified as follows:[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
[5]Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017 Dec;40(12):1631-40.
https://diabetesjournals.org/care/article/40/12/1631/37000/International-Consensus-on-Use-of-Continuous
http://www.ncbi.nlm.nih.gov/pubmed/29162583?tool=bestpractice.com
[17]McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.
https://academic.oup.com/jcem/article/108/3/529/6880627
http://www.ncbi.nlm.nih.gov/pubmed/36477488?tool=bestpractice.com
Level 3 (severe): no defined blood glucose. A severe event with no defined blood glucose, characterised by altered mental and/or physical status requiring assistance for treatment of hypoglycaemia.
Level 2 (clinically significant; also referred to as clinically important or serious): blood glucose <3.0 mmol/L (<54 mg/dL). This is usually the threshold at which neuroglycopenic symptoms occur, but bear in mind that symptoms of hypoglycaemia usually occur at a higher blood glucose level in children than in adults. In addition, be aware that a patient with impaired awareness of hypoglycaemia may not present with typical signs and symptoms of hypoglycaemia.
Level 1 (alert value): blood glucose <3.9 mmol/L (<70 mg/dL) and ≥3.0 mmol/L (≥54 mg/dL). Advise the patient that this value should alert them to the possibility of developing level 2 hypoglycaemia and can be used as a threshold to take appropriate actions to prevent this (e.g., carbohydrate ingestion, adjusting drug treatment).
Clinical presentation
Suspect diabetic hypoglycaemia if a patient with diabetes presents with:[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
[17]McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.
https://academic.oup.com/jcem/article/108/3/529/6880627
http://www.ncbi.nlm.nih.gov/pubmed/36477488?tool=bestpractice.com
[80]Cryer PE, Arbeláez AM. Hypoglycemia. In: Shlomo M, Auchus RJ, Goldfine AB, et al, eds. Williams textbook of endocrinology. 14th ed. Philadelphia, PA: Elsevier, Inc; 2020;1525-51.[81]Frier BM. Hypoglycaemia and cognitive function in diabetes. Int J Clin Pract Suppl. 2001 Sep;(123):30-7.
http://www.ncbi.nlm.nih.gov/pubmed/11594296?tool=bestpractice.com
Life-threatening alterations in mental and/or physical functioning. These indicate severe (level 3) hypoglycaemia if they require assistance from another person for recovery, and can include or progress to:
Seizure
Loss of consciousness
Coma
Death
Any typical signs and symptoms of hypoglycaemia, which can be categorised as:
Neuroglycopenic:
Sympathoadrenal:
Shakiness
Sweating
Tremor
Palpitations
Tachycardia
Feeling warm
Anxiety
Nausea
Hunger
Pallor
A fall or motor vehicle accident.
These can occur due to reduced consciousness level as a result of hypoglycaemia. In these scenarios, always ascertain the preceding events or precipitants that led to the fall or accident. This is key to identify because hypoglycaemia that causes unconsciousness needs to be addressed to avoid future catastrophes.
Other features include a higher blood glucose than usual when waking up, and bedwetting.
Note that:
Signs and symptoms of hypoglycaemia usually occur at a higher blood glucose level in children than in adults.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Sympathoadrenal signs and symptoms typically occur before neuroglycopenic symptoms in both children and adults.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
In people without diabetes, sympathoadrenal symptoms may occur from a blood glucose of 3.0 to 3.4 mmol/L (54-61 mg/dL).[82]Verhulst CEM, Fabricius TW, Teerenstra S, et al. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review. Diabetologia. 2022 Oct;65(10):1601-12.
https://link.springer.com/article/10.1007/s00125-022-05749-8
http://www.ncbi.nlm.nih.gov/pubmed/35867127?tool=bestpractice.com
However, in people with diabetes and chronic recurrent hypoglycaemia, symptoms may occur at a lower blood glucose (and at a higher blood glucose in people with diabetes and chronic hyperglycaemia).[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Neuroglycopenic signs and symptoms typically occur at blood glucose of <3.0 mmol/L (<54 mg/dL).[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
In children (particularly those aged <6 years in practice), these are more common than sympathoadrenal signs and symptoms.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[83]Tupola S, Rajantie J. Documented symptomatic hypoglycaemia in children and adolescents using multiple daily insulin injection therapy. Diabet Med. 1998 Jun;15(6):492-6.
http://www.ncbi.nlm.nih.gov/pubmed/9632124?tool=bestpractice.com
Behavioural changes such as irritability, agitation, quietness, and tantrums may be prominent in pre-school children.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
In children, always record severe hypoglycaemia that has caused coma or seizure and required parenteral treatment as 'hypoglycaemic coma'.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
This scenario is a subset of severe hypoglycaemia and should be recorded separately to other forms of severe hypoglycaemia because of the increased risk of repeated severe events.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Be aware that some patients may not present with typical symptoms of hypoglycaemia, particularly if they have impaired awareness of hypoglycaemia.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
Patients with impaired awareness of hypoglycaemia are at risk of severe (level 3) hypoglycaemia.[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
Beta-blockers may also reduce symptoms of hypoglycaemia in some patients. The neuroglycopenic response to hypoglycaemia is sympathoadrenal in nature, which can be masked by beta-blockers.[65]Dungan K, Merrill J, Long C, et al. Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients. Cardiovasc Diabetol. 2019 Nov 27;18(1):163.
https://cardiab.biomedcentral.com/articles/10.1186/s12933-019-0967-1
http://www.ncbi.nlm.nih.gov/pubmed/31775749?tool=bestpractice.com
[84]McCall AL. Insulin therapy and hypoglycemia. Endocrinol Metab Clin North Am. 2012 Mar;41(1):57-87.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265808
http://www.ncbi.nlm.nih.gov/pubmed/22575407?tool=bestpractice.com
However, sweating remains unmasked and this may be the only symptom of hypoglycaemia.[46]Muneer M. Hypoglycaemia. Adv Exp Med Biol. 2021;1307:43-69.
http://www.ncbi.nlm.nih.gov/pubmed/32406022?tool=bestpractice.com
History
Take a careful history to identify any risk factors for diabetic hypoglycaemia.
Urgently check if the patient has had previous episodes of level 2 and/or level 3 hypoglycaemia, in order to intervene quickly and prevent further episodes.[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
Patients with previous level 3 hypoglycaemia are at particularly increased risk of further episodes of hypoglycaemia.[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
[17]McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.
https://academic.oup.com/jcem/article/108/3/529/6880627
http://www.ncbi.nlm.nih.gov/pubmed/36477488?tool=bestpractice.com
See Diagnostic criteria.
Include in your history any drug the patient is taking that may increase the risk of hypoglycaemia. These include:
Anthyperglycaemic drugs. Certain glucose-lowering drugs increase the risk of hypoglycaemia compared with others, including:[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[46]Muneer M. Hypoglycaemia. Adv Exp Med Biol. 2021;1307:43-69.
http://www.ncbi.nlm.nih.gov/pubmed/32406022?tool=bestpractice.com
Beta-blockers[41]Bansal N, Weinstock RS, Feingold KR, et al, eds. Non-diabetic hypoglycemia. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000 (updated 2020).
https://www.ncbi.nlm.nih.gov/books/NBK355894
http://www.ncbi.nlm.nih.gov/pubmed/27099902?tool=bestpractice.com
[65]Dungan K, Merrill J, Long C, et al. Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients. Cardiovasc Diabetol. 2019 Nov 27;18(1):163.
https://cardiab.biomedcentral.com/articles/10.1186/s12933-019-0967-1
http://www.ncbi.nlm.nih.gov/pubmed/31775749?tool=bestpractice.com
These can mask the symptoms and signs of hypoglycaemia, which can predispose patients to severe, life-threatening hypoglycaemia. Non-selective beta-blockers can also impair hepatic and renal release of glucose into the circulation, which can cause hypoglycaemia.
Many other drugs (e.g., certain antibiotics [particularly sulfonamides and fluoroquinolones], quinine, pentamidine, indometacin) have been linked to hypoglycaemia in patients without diabetes, but the evidence is unclear as to whether they cause hypoglycaemia in patients with diabetes.[41]Bansal N, Weinstock RS, Feingold KR, et al, eds. Non-diabetic hypoglycemia. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000 (updated 2020).
https://www.ncbi.nlm.nih.gov/books/NBK355894
http://www.ncbi.nlm.nih.gov/pubmed/27099902?tool=bestpractice.com
This list of drugs is not exhaustive, and you should consult a drug information source for more information.
Identify any other risk factors for hypoglycaemia in patients who have diabetes, in order to determine their risk of future episodes, and to minimise the occurrence of these. These include:[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[2]Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013 May;36(5):1384-95.
https://diabetesjournals.org/care/article/36/5/1384/29546/Hypoglycemia-and-Diabetes-A-Report-of-a-Workgroup
http://www.ncbi.nlm.nih.gov/pubmed/23589542?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
[14]Joint British Diabetes Societies for Inpatient Care (JBDS-IP). The hospital management of hypoglycaemia in adults with diabetes mellitus. Jan 2023 [internet publication].
https://abcd.care/sites/abcd.care/files/site_uploads/JBDS_Guidelines_Current/JBDS_01_Hypo_Guideline_with_QR_code_January_2023.pdf
[17]McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.
https://academic.oup.com/jcem/article/108/3/529/6880627
http://www.ncbi.nlm.nih.gov/pubmed/36477488?tool=bestpractice.com
[36]Adolfsson P, Taplin CE, Zaharieva DP, et al. ISPAD clinical practice consensus guidelines 2022: exercise in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1341-72.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13452
[41]Bansal N, Weinstock RS, Feingold KR, et al, eds. Non-diabetic hypoglycemia. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000 (updated 2020).
https://www.ncbi.nlm.nih.gov/books/NBK355894
http://www.ncbi.nlm.nih.gov/pubmed/27099902?tool=bestpractice.com
[67]Cohn A, Sofia AM, Kupfer SS. Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis. Curr Diab Rep. 2014 Aug;14(8):517.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156157
http://www.ncbi.nlm.nih.gov/pubmed/24952108?tool=bestpractice.com
[85]Lacherade JC, Jacqueminet S, Preiser JC. An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol. 2009 Nov 1;3(6):1242-9.
https://journals.sagepub.com/doi/epdf/10.1177/193229680900300603
http://www.ncbi.nlm.nih.gov/pubmed/20144377?tool=bestpractice.com
Type 1 diabetes
Extremes of age (adults >60 years and young children)
Suboptimal glycaemic control, including high glycaemic variability
Intensive glycaemic control efforts (low [<6%] or high [>9%] HbA1c levels)
Increased duration of diabetes
Treatment with insulin >5 years
Impaired cognitive function
Impaired awareness of hypoglycaemia
First trimester of pregnancy
Failure to thrive in children
Poor oral intake (e.g., if there is food insecurity or reduced intake of carbohydrates), weight loss, or malnutrition
Exercise
Renal impairment (e.g., chronic kidney disease, acute kidney injury)
Liver dysfunction
Endocrine disorders (e.g., adrenal insufficiency, hypothyroidism, coeliac disease)
Critical illness (e.g., sepsis)
Alcohol ingestion.
In addition, be aware that patients are at particular risk of severe or asymptomatic hypoglycaemia during sleep (nocturnal hypoglycaemia) because sleep impairs the counter-regulatory hormone response to hypoglycaemia.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Suspect nocturnal hypoglycaemia if the patient has any of:[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Low pre-breakfast blood glucose
Episodes of confusion, nightmares, or seizures at night
Impaired thinking, altered mood, or headaches when waking up in the morning.
Investigations
Blood glucose
Urgently carry out a blood glucose level for any patient with suspected diabetic hypoglycaemia, which is a finger stick test that is performed at the bedside or in an outpatient setting. In practice, if finger stick testing is not available, start treatment if the patient has typical symptoms and signs of hypoglycaemia.
Confirm diabetic hypoglycaemia if blood glucose is <3.9 mmol/L (<70 mg/dL).[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
In clinical practice, this is used as the clinical alert or threshold value that should prompt treatment for hypoglycaemia in diabetes to prevent a further fall in blood glucose.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[2]Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013 May;36(5):1384-95.
https://diabetesjournals.org/care/article/36/5/1384/29546/Hypoglycemia-and-Diabetes-A-Report-of-a-Workgroup
http://www.ncbi.nlm.nih.gov/pubmed/23589542?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
However, be aware that hypoglycaemia is defined as any fall in blood glucose that exposes a patient to potential harm as there is no single numerical definition of hypoglycaemia for all patients and situations.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Suspect nocturnal hypoglycaemia if the patient's pre-breakfast blood glucose is low.[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
Take appropriate action according to the severity of the hypoglycaemia.[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
Start immediate treatment for any patient with clinically significant (level 2) or severe (level 3) hypoglycaemia.[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
Severity of diabetic hypoglycaemia is classified as follows:[1]Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.
https://onlinelibrary.wiley.com/doi/10.1111/pedi.13443
http://www.ncbi.nlm.nih.gov/pubmed/36537534?tool=bestpractice.com
[3]American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025. Jan 1; 48(Suppl 1):S1-343.
https://diabetesjournals.org/care/issue/48/Supplement_1
[4]Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021 Dec;64(12):2609-52.
https://link.springer.com/article/10.1007/s00125-021-05568-3
http://www.ncbi.nlm.nih.gov/pubmed/34590174?tool=bestpractice.com
[5]Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017 Dec;40(12):1631-40.
https://diabetesjournals.org/care/article/40/12/1631/37000/International-Consensus-on-Use-of-Continuous
http://www.ncbi.nlm.nih.gov/pubmed/29162583?tool=bestpractice.com
[17]McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.
https://academic.oup.com/jcem/article/108/3/529/6880627
http://www.ncbi.nlm.nih.gov/pubmed/36477488?tool=bestpractice.com
Level 3 (severe): no defined blood glucose. A severe event characterised by altered mental and/or physical status requiring assistance for treatment of hypoglycaemia.
Level 2 (clinically significant; also referred to as clinically important or serious): blood glucose <3.0 mmol/L (<54 mg/dL). This is usually the threshold at which neuroglycopenic symptoms occur, but bear in mind that symptoms of hypoglycaemia usually occur at a higher blood glucose level in children than in adults. In addition, be aware that a patient with impaired awareness of hypoglycaemia may not present with typical signs and symptoms of hypoglycaemia.
Level 1 (alert value): blood glucose <3.9 mmol/L (<70 mg/dL) and ≥3.0 mmol/L (≥54 mg/dL). Advise the patient that this value should alert them to the possibility of developing level 2 hypoglycaemia and can be used as a threshold to take appropriate actions to prevent this (e.g., carbohydrate ingestion, adjusting drug treatment).
Exclusion of other causes
Always consider other, non-diabetic causes of hypoglycaemia. In clinical practice, a non-diabetic aetiology should be particularly suspected if the episodes of hypoglycaemia:
Cannot be related to timing of insulin injections, increased activity, or reduced carbohydrate intake
Persist despite changes of insulin doses
Are associated with ketonuria or ketonaemia
Are associated with risk factors for non-diabetic causes of hypoglycaemia.
Other causes of non-diabetic hypoglycaemia include:[17]McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.
https://academic.oup.com/jcem/article/108/3/529/6880627
http://www.ncbi.nlm.nih.gov/pubmed/36477488?tool=bestpractice.com
For more information, see Differentials.
See also Non-diabetic hypoglycaemia.